スポンサーリンク
Medicine Iii Osaka University Medical School | 論文
- Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
- Different Kinetics of WT1 and PML-RARα Gene Expression Levels during Remission Induction Therapy with All-trans Retinoic Acid Alone in Acute Promyelocytic Leukemia
- Effect of heparin addition on expansion of cord blood hematopoietic progenitor cells in three-dimensional coculture with stromal cells in nonwoven fabrics
- Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
- Analysis of Hematopoietic Microenvironment Containing Spatial Development of Stromal Cells in Nonwoven Fabrics (ANIMAL BIOTECHNOLOGY)
- Lethal Adenovirus Infection in a Patient Who Had Undergone Nonmyeloblative Stem Cell Transplantation
- Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
- High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
- Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
- Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
- Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
- Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
- WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
- Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
- A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells
- Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene